Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04883398 · ClinicalTrials.gov registry record
A Study of Attention and Memory Processes in Breast Cancer Survivors
A clinical trial of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT04883398: Active study of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04883398 is a study of Breast Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 65 participants, below the 2,753-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04883398, a study of Breast Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe the attention and memory processes in breast cancer survivors. Both cancer survivors and healthy volunteers (who are the same age as the cancer survivors) will participate in this study so we can compare the results of testing on each group of participants.
Primary Outcome
Using EEG measures of brain activity during a cognitive-experimental long-term memory task to evaluate the mechanisms underlying attention, initial learning, retrieval, and metamemory performance. P3 amplitude as measured by EEG at the Pz electrode.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-05-06 |
| Est. Completion | 2026-05 |
What the registry record for NCT04883398 still lists
NCT04883398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 2,753-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 0 interventions.
NCT04883398 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04883398 about?
NCT04883398 is a clinical study titled "A Study of Attention and Memory Processes in Breast Cancer Survivors". The purpose of this study is to observe the attention and memory processes in breast cancer survivors. Both cancer survivors and healthy volunteers (who are the same age as the cancer survivors) will participate in this study so we can compare the results of testing on each group of participants.
What is the current status of trial NCT04883398?
This trial is currently active not recruiting. The enrollment target is 65 participants. The study started on 2021-05-06. Estimated completion is 2026-05.
What conditions does trial NCT04883398 study?
This clinical trial studies the following conditions: Breast Cancer Survivors.
Who is sponsoring clinical trial NCT04883398?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04883398 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04883398's enrollment target sits among peer trials
65 8th of 8 higher than 1 of 8 other Breast Cancer Survivors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Survivors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rowing Following Breast Cancer Chemotherapy
RECRUITING · NA
-
UCF MammoChat: Image Repository
RECRUITING
-
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
RECRUITING
-
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
ACTIVE NOT RECRUITING
-
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History
ACTIVE NOT RECRUITING
-
Improving Cognition After Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI